(Q33497313)

English

Efficacy and side effects of intermittent recombinant interferon-alpha 2a in chronic aggressive hepatitis C: with or without initial daily administration

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Efficacy and side effects of intermittent recombinant interferon-alpha 2a in chronic aggressive hepatitis C: with or without initial daily administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

H Itoh

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

H Nakata

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Y Yokoya

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

S Nakashima

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

T Yamanishi

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

T Hara

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J Kawai

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

H Miyamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

K Higashi

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

S Nishioka

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

718-723

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00320.X

21 January 2018

Identifiers

10.1111/J.1440-1746.1996.TB00320.X

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33497313&oldid=1978650679"